BrawnP. N., AyalaA. G., Van EschenbachA. C., HusseyD. H., JohnsonD. E.: Histologic grading study of prostate adenocarcinoma. Cancer, 49; 525–532 (1982).
2.
EllisD. W., LeffersS., Stewart DaviesJ., AlanB. P.: Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate. Amer. J. Clin. Pathol., 81; 279–284 (1984).
3.
Gupta RajK., SchusterR., ChristianW. D.: Loss of isoantigens A, B and H in prostate. Amer. J. Pathol., 70; 439–488 (1973).
4.
MellingerG. T., GleasonD., BailarJ.: The histology and prognosis of prostatic cancer. J. Urol., 97; 331–338 (1967).
5.
NadijM., TabeiS. Z., CastroA., ChuT. M., MurphyG. P., WangM. C., MoralesA. R.: Prostatic specific antigen: an immunoistologic marker for prostatic neoplasm. Cancer, 48; 1229–1232 (1981).
6.
PrambergB. A., KarnikS., WalkerP. D., De KernionJ. B.: Tumor blood group antigens in prostatic carcinoma. Sring Meeting of the American Society of Clinical Pathologist, San Diego California 1981.
7.
SternbergerL. A., HardyP. H.Jr., CuculisJ. J., MeyerH. G.: The unlabeled antibody-enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidaseantihorseradish peroxidase) and its use in identification of spirochetes J. Histochem. Cytochem., 18; 315–333 (1970).
8.
WangM. C., ValenzuelaL. A., MurphyG. P., ChuT. M.: Purification of human prostate specific antigen. Invest. Urol., 17; 159–168 (1979).